Published in Medical Letter on the CDC and FDA, September 28th, 2008
Study data show longer term efficacy and safety and tolerability profile of JANUVIA up to two years
JANUVIA and metformin as initial combination therapy demonstrated significant glucose-lowering efficacy over two years Pooled analysis of 6,139 patients showed JANUVIA was generally well tolerated in clinical trials, up to two years in duration Investigational study of the addition of JANUVIA to the combination of metformin and rosiglitazone significantly improved blood sugar control 52-week study of Japanese patients with an investigational...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA